Search

In conversation with Uliana Gout

We were delighted to catch up with Dr Uliana Gout, President of the British College of Aesthetic Medicine (BCAM), about her career and plans for the College. Can you tell us a little bit about why you initially chose to...

Behind the scenes of MZ Skin

Facial Aesthetics and Oculoplastic Surgeon Maryam Zamani takes us on her journey from the vision of creating a scientifically backed skincare range for women to the reality of her brand, MZ Skin, being launched onto the shelves of Harrods. We...

Focus on Cosmeceuticals: Definitions, regulations and a review of the market

In the previous section of this special focus, the structure and function of the skin has been reviewed as well as the cutaneous changes induced by UV exposure. This section will define the term cosmeceutical and discuss the current market...

Virtual learning post lockdown

The rapid onset and intensity of the COVID-19 pandemic has required some radical changes in most areas of our professional lives, including a chance to update traditional approaches to learning. Virtual learning is the use of remote video conferencing software,...

In conversation with Dr Benjamin Ascher (2019)

The PMFA Journal was delighted to chat to internationally renowned plastic surgeon Dr Benjamin Ascher for his thoughts on training and changes to the world of aesthetics. Dr Benjamin Ascher How have things changed since you first started working in...

An overview of chemical peel formulations

This article has been verified for CPD. Click the button below to answer a few short questions and download a form to be included in your CPD folder. Chemical peels continue to be one of the most popular aesthetic treatments....

Periocular burns: a literature review of classification, management protocols and outcomes of treatment

The author provides a review of the current literature regarding the principles of classification, management protocols of acute ocular and periocular burns and the role of the burn and oculoplastic surgeon involved in their care. More than two-thirds of facial...

A short overview of the evolution of botulinum toxin type A formulations

Botulinum toxin type A (BoNT-A) is a potent neurotoxin produced by the bacterium Clostridium botulinum [1]. BoNT-A has been used for various therapeutic and aesthetic purposes, including the treatment of muscle disorders, chronic pain and facial wrinkles [2-4]. Over the...